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The EQ-5D is arguably now the most well-known and
commonly used generic measure of health status interna-
tionally. It is available in 169 languages, with applications in
clinical, cost-effectiveness and population health studies, as
well as (more recently) its routine use by health-care sys-
tems. A key feature of the EQ-5D is the availability of ‘value
sets’ to weight the EQ-5D health states reported by patients
and populations. These value sets provide, for each of the
243 health states described by the EQ-5D, a value (‘utility’)
on a scale anchored at 1 (full health) and 0 (dead), reflecting
the preferences of the general public, which can be used to
estimate quality-adjusted life years (QALYs). These value
sets are widely used in the analysis of EQ-5D data and
inform a wide range of resource allocation decisions. Value
sets for the 3-level version of the EQ-5D (3L) are available
in 18 countries and are generally regarded as a credible basis
for decision making—for example, the UK value set
reported by [1] is recommended by NICE for use in its health
technology appraisal process [2]. However, these value sets
were largely the result of locally led researcher initiatives.
The EuroQol Group never developed or promulgated a
formal protocol for the conduct of EQ-5D valuation studies,
with the result that value sets studies around the world were
undertaken using somewhat inconsistent methods for elic-
iting, analysing and modelling preferences data.
As use of the EQ-5D has become more common over
the last few decades, a growing body of evidence has
developed on both its merits and limitations as a health-
status measure. Whilst in many applications the EQ-5D has
been shown to be a valid and reliable measure of patient
health, it has also been argued that in some contexts the
three-level version of the EQ-5D may lack sensitivity or
fail to capture important aspects of health in certain disease
areas. To address this issue, the EuroQol Group has
undertaken an ambitious research and development pro-
gramme aimed at the development of a more sensitive
health-status measurement instrument. One of the recent
developments was a five-level version, the EQ-5D-5L [3].
An interim set of values for the EQ-5D-5L is available
from a cross-over study [4], allowing values for EQ-D-5L
states to be assigned from the existing EQ-5D (3L) value
sets. But such methods have their limitations—and ulti-
mately decision makers will require EQ-5D-5L value sets
that reflect the preferences of the general public over both
the dimensions and the expanded levels of the new
instrument.
The need to produce value sets to accompany the EQ-
5D-5L therefore presented an opportunity to both advance
the methods for health-state valuation and develop an
agreed protocol to be followed by all countries aiming to
produce an EQ-5D-5L value set. In anticipation of the
requirement for value sets to accompany the new EQ-5D-
5L, the EuroQol Group initiated a programme of method-
ological research, aimed at overcoming well-known prob-
lems and limitations with the time trade-off (TTO)
approach that had been used in valuing the three-level
version of the EQ-5D and testing the use of discrete choice
(DC) methods to value EQ-5D-5L. The conventional
approach to TTO is known to have some important prob-
lems, particularly relating to the way values are obtained
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for health states considered to be worse than dead (i.e.,
values \0). For example, the conventional TTO uses
conceptually different approaches to the valuation of states
better than dead and worse than dead, resulting in arbi-
trarily large negative values. Traditionally, this has been
redressed by a transformation of the negative values to a
range with a minimum of -1. To address the issues, the
EuroQol Group initiated research to develop new methods
for TTO, resulting in the identification of two potential
alternative approaches—the ‘lead-time’ and ‘lag- time’
TTO.
In addition to improving and testing valuation meth-
ods, there are additional challenges posed by the valua-
tion of EQ-5D-5L compared to the EQ-5D-3L: most
obviously, there are more states to value (3,125 as
opposed to 243). More importantly, the more subtle
semantic differences between the levels (for example,
between ‘severe’ and ‘extreme’ problems, levels 4 and 5,
respectively) mean that it is potentially more difficult for
participants in valuation tasks to differentiate between the
states they are asked to consider. It was therefore
important to test and evaluate the preferences data that
would be produced for EQ-5D-5L states using the
methods under consideration.
The articles in this issue of the European Journal of
Health Economics report in detail on an ambitious pro-
gramme of research undertaken by the EuroQol Group to
achieve those aims. Specifically, these articles draw toge-
ther the findings from a multi-country pilot study to test an
initial version of the study protocol and related experi-
mentation with aspects of the methods in that protocol.
This included experiments regarding a number of aspects
of the TTO, including a comparison of the lead and lag-
time TTO (Augustovski et al.), a comparison of both those
approaches with the conventional TTO (Versteegh et al.),
alternative ways of displaying the lead-time TTO (Luo
et al.) and experiments with alternative lengths of time in
both full health and the state being valued (Versteegh et al.
and Luo et al.). All the studies in the multi-country pilot
included both TTO and DC methods; the article by Ramos-
Goni et al. reports on the use of DC data to value EQ-5D-
5L states and on the potential to combine DC with direct
comparisons of each state with ‘dead’, as a means of
anchoring to 0. Finally, this series of papers ends with two
articles that each address related issues. Based on in depth
study of the literature, Attema et al. present an overview of
the various alternative specifications that exist for the TTO.
In the last article, Shah et al. present results of a separate
investigation on the characteristics and the quality of the
data generated in settings for administering TTO tasks if
based on computer-assisted interviews that were inter-
viewer-led (one-to-one) versus the same TTO tasks in a
self-complete setting (with group assistance).
The research reported here helped to inform decisions
about the final international protocol to be used in studies to
produce value sets for the EQ-5D-5L [5]. For example, a key
finding of the work described in the following articles, and
summarised in the article by Shah et al. in this issue, was the
clear importance of administering TTO tasks in face-to-face
interviews—alternative modes of data collection, such as
allowing respondents to self-complete TTO tasks in group
sessions, compromised the credibility of the data. Addition-
ally, whilst the lead-time TTO has advantages over the con-
ventional approach in eliciting values\0, earlier research had
highlighted concerns about the choice of the length of the lead
time exerting a framing effect on values [6]. A ‘composite
TTO’ approach appeared to provide a promising alternative,
by using the conventional approach to the elicitation of values
[0, and using the lead time approach for values\0. This was
tested for the first time in The Netherlands, and the results
reported in this issue showed that the method produced highly
credible data (Janssen et al.).
The final protocol, described in detail in Oppe et al. [5],
includes software for use in computer-assisted personal
interviews, an interviewer script, interviewer training
materials, guidance to researchers and tools for data anal-
ysis. The protocol employs a combination of methods—
both the composite TTO and DC—for the valuation of EQ-
5D-5L states. The articles constitute an important body of
work that helped refine and improve the methods in the
protocol and will now be rolled out in a series of pivotal
studies internationally. Value sets using these methods will
be reported later this year in The Netherlands, Spain,
England, Canada and China. Further studies are now
underway or planned in Japan, Taiwan, South Korea,
Germany, Uruguay, Thailand, Hong Kong and Singapore,
with interest expressed also from others. We confidently
expect there to be many more EQ-5D-5L value sets
available than was the case for EQ-5D-3L, ensuring that
appropriate value sets will be available for use in local
applications of the instrument.
For the first time, the EuroQol Group has a fully doc-
umented research protocol. This will ensure that studies are
undertaken to a high standard, using a consistent study
design and methods for collecting health-state values.
Ultimately, this will also create a unique opportunity for
international comparisons of values for EQ-5D-5L. Of
course, inevitably there are many remaining methodologi-
cal issues, which can and will be addressed in ongoing
research—but the international protocol represents a sig-
nificant achievement for the EuroQol Group, and a step
forward in the use and application of the EQ-5D-5L.
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